Coherus.com


Keyword Suggestion

Coherus
Coherus biosciences
Coherus stock price
Coherus stock
Coherus solutions
Coherus news
Coherus complete
Coherus biosciences stock
Coherus ir
Coherus yahoo finance
Coherus biosciences careers
Coherus stocktwits
Coherus careers
Coherus biosciences stock price
Coherus biosimilar
Coherus investor relations
Coherus diskussion
Coherus bioscience news today
Coherus biosciences news
Coherus cimerli
Coherus pharmaceuticals
Coherus complete copay program



Domain Informations

Coherus.com lookup results from whois.godaddy.com server:
  • Domain created: 2012-04-18T18:09:52Z
  • Domain updated: 2022-09-11T21:40:17Z
  • Domain expires: 2026-04-18T18:09:52Z 1 Year, 363 Days left
  • Website age: 12 Years, 1 Day
  • Registrar Domain ID: 1714336951_DOMAIN_COM-VRSN
  • Registrar Url: http://www.godaddy.com
  • Registrar WHOIS Server: whois.godaddy.com
  • Registrar Abuse Contact Email: [email protected]
  • Registrar Abuse Contact Phone: 480-624-2505
  • Name server:
    • CLARK.NS.CLOUDFLARE.COM
    • DORTHY.NS.CLOUDFLARE.COM

Network
  • inetnum : 141.193.213.0 - 141.193.213.255
  • name : WPENG
  • handle : NET-141-193-213-0-1
  • status : Direct Allocation
  • created : 2020-03-20
  • changed : 2020-07-14
Owner
  • organization : WPEngine, Inc.
  • handle : WPENG
  • address : Array,Austin,TX,78701,US
Technical support
Abuse
Domain Provider Number Of Domains
godaddy.com 286730
namecheap.com 101387
networksolutions.com 69118
tucows.com 52617
publicdomainregistry.com 39120
whois.godaddy.com 32793
enomdomains.com 23825
namesilo.com 21429
domains.google.com 21384
cloudflare.com 20573
gmo.jp 18110
name.com 17601
fastdomain.com 14708
register.com 13495
net.cn 12481
ionos.com 12416
ovh.com 12416
gandi.net 12305
registrar.amazon.com 12111


Host Informations

  • IP address: 141.193.213.11
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Check all domain's dns records


See Web Sites Hosted on 141.193.213.11

Fetching Web Sites Hosted


Site Inspections


Port Scanner (IP: 141.193.213.11)

 › Ftp: 21
 › Ssh: 22
 › Telnet: 23
 › Smtp: 25
 › Dns: 53
 › Http: 80
 › Pop3: 110
 › Portmapper, rpcbind: 111
 › Microsoft RPC services: 135
 › Netbios: 139
 › Imap: 143
 › Ldap: 389
 › Https: 443
 › SMB directly over IP: 445
 › Msa-outlook: 587
 › IIS, NFS, or listener RFS remote_file_sharing: 1025
 › Lotus notes: 1352
 › Sql server: 1433
 › Point-to-point tunnelling protocol: 1723
 › My sql: 3306
 › Remote desktop: 3389
 › Session Initiation Protocol (SIP): 5060
 › Virtual Network Computer display: 5900
 › X Window server: 6001
 › Webcache: 8080


Spam Check (IP: 141.193.213.11)

 › Dnsbl-1.uceprotect.net:
 › Dnsbl-2.uceprotect.net:
 › Dnsbl-3.uceprotect.net:
 › Dnsbl.dronebl.org:
 › Dnsbl.sorbs.net:
 › Spam.dnsbl.sorbs.net:
 › Bl.spamcop.net:
 › Recent.dnsbl.sorbs.net:
 › All.spamrats.com:
 › B.barracudacentral.org:
 › Bl.blocklist.de:
 › Bl.emailbasura.org:
 › Bl.mailspike.org:
 › Bl.spamcop.net:
 › Cblplus.anti-spam.org.cn:
 › Dnsbl.anticaptcha.net:
 › Ip.v4bl.org:
 › Fnrbl.fast.net:
 › Dnsrbl.swinog.ch:
 › Mail-abuse.blacklist.jippg.org:
 › Singlebl.spamgrouper.com:
 › Spam.abuse.ch:
 › Spamsources.fabel.dk:
 › Virbl.dnsbl.bit.nl:
 › Cbl.abuseat.org:
 › Dnsbl.justspam.org:
 › Zen.spamhaus.org:


Email address with coherus.com

Found 1 emails of this domain
1. [email protected]

Recent Searched Sites

Ssoft.su (43 seconds ago) / RU

Celestron.com (13 seconds ago) / CA

Exam.siiibtorsh.com (52 seconds ago) / IR

Kimet.fi (53 seconds ago) / US

Basketball-database.com (33 seconds ago) / NL

Threevalleysradio.com (43 seconds ago) / GB

Instaon.io (1 seconds ago) / US

Mijnrijbewijs.eu (18 seconds ago) / NL

Coherus.com (0 seconds ago) / US

Friendlysonsnyc.com (8 seconds ago) / US

Metrozemin.com (0 seconds ago) / TR

Esthetique-osaka.com (18 seconds ago) / JP

Fireandsteel.ca (12 seconds ago) / CA

Greenvillenc.gov (3 mins ago) / US

Healthnow.ph (53 seconds ago) / US

Thetimes.co.uk (29 seconds ago) / IE

Locfederal.branch-locations.com (8 seconds ago) / US

Purmalis.ru (18 seconds ago) / RU

Coviamg.com (16 seconds ago) / US

Drqidwai.com.au (1 mins ago) / US

Websites Listing

We found Websites Listing below when search with coherus.com on Search Engine

Coherus

The current areas of focus of Coherus are to promote health-related programs of 501(c) 3 organizations, certain charitable events in support of community health and health education, wellness, scholarships or supporting the education of students to support programmatic activities and scholarships of 501(c) 3 organizations, including hospital foundations.

Grants.coherus.com

Highlights | Coherus BioSciences, Inc.

The Board of Directors of Coherus BioSciences, Inc. (the "Company") sets high standards for the Company's employees, officers and directors. Implicit in this philosophy is the importance of sound corporate governance. It is the duty of the Board of Directors to serve as a prudent fiduciary for shareholders and to oversee the management of the ...

Investors.coherus.com

investors.coherus.com

Investors.coherus.com

Investors.coherus.com

COVERAGE HOME - Coherus COMPLETE

Access to Commercial, Medicare, Medicaid, or other Government Insurance Coverage Begins Here

Coheruscomplete.com

About Coherus - UDENYCA®

At Coherus, we manufacture UDENYCA® with a commitment to high quality, not high cost. Our promise. To offer those in need, whose viability depends on it—patients, healthcare professionals, institutions, and payers—the opportunity to choose the healthcare that will benefit patients the most. Coherus has brought to market a new standard of competition, embracing change and …

Udenyca.com

Coherus BioSciences Announces New Employment Inducement …

2022-06-23  · Coherus BioSciences, Inc., announced that effective June 16, 2022, the compensation committee of the Company’s board of directors granted options to purchase an aggregate of 409,000 shares of the common stock of the Company to 16 newly hired employees with a per share exercise price of $5.86, the closing trading price on the grant date.

Biospace.com

Coherus and Junshi Biosciences Receive Complete Response Letter …

2022-05-02  · About Coherus BioSciences. Coherus is a commercial stage biopharmaceutical company building a leading immuno-oncology franchise funded with cash generated by its commercial biosimilar business. In 2021, Coherus in-licensed toripalimab, an anti-PD-1 antibody, in the United States and Canada. Coherus plans to resubmit a BLA for toripalimab for ...

Investors.coherus.com

Coherus BioSciences Announces New Employment Inducement

2022-06-22  · The stock options were granted pursuant to the Coherus BioSciences, Inc. 2016 Employment Commencement Incentive Plan, which was approved by the Company’s board of directors in June 2016 under ...

Globenewswire.com

Senior Scientist/Principal Scientist in the Molecular Interactions ...

2021-10-19  · E-mail: [email protected]. Beginning July 19, 2021, Coherus BioSciences requires all new hires to be fully vaccinated against COVID-19 as of their start date. This requirement is a condition of employment at Coherus BioSciences, and it applies regardless of whether the position is located at a Coherus BioSciences facility or is fully remote. If ...

Ziprecruiter.com

Coherus BioSciences Announces New Employment Inducement …

2022-05-05  · The stock options were granted pursuant to the Coherus BioSciences, Inc. 2016 Employment Commencement Incentive Plan, which was approved by the Company’s board of directors in June 2016 under Rule 5635(c)(4) of the Nasdaq Global Select Market for equity grants to induce new employees to enter into employment with the Company.

Stocktitan.net

Coherus Biosciences Terminates Deal With Innovent for Avastin …

2022-05-06  · In Coherus Biosciences' earnings conference call for the first quarter (Q1) of 2022, the company announced it has discontinued development of a bevacizumab biosimilar candidate (CHS-305; IBI-305; Byvasda). Coherus entered into a license agreement with Innovent Biologics for the candidate in January 2020. Under the partnership, Coherus was to have the …

Centerforbiosimilars.com

Coherus BioSciences Company Profile - Craft

2022-04-27  · Coherus BioSciences has 310 employees across 2 locations and $475.82 M in annual revenue in FY 2020. See insights on Coherus BioSciences including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.

Craft.co

Coherus Biosciences, Inc. in Oklahoma City, OK | Company Info

Coherus Biosciences, Inc. is an Oklahoma Foreign For-Profit Business Corporation filed On November 12, 2020. The company's filing status is listed as In Existence and its File Number is 2312891530. The Registered Agent on file for this company is CT Corporation System and is located at 1833 S Morgan Rd, Oklahoma City, OK 73128.

Bizapedia.com

Coherus BioSciences hiring Manager/Senior Manager, Purchasing ...

Beginning July 19, 2021, Coherus BioSciences requires all new hires to be fully vaccinated against COVID-19 as of their start date. This requirement is a …

Linkedin.com

Coherus BioSciences hiring Product Development Internship in

Beginning July 19, 2021, Coherus BioSciences requires all new hires to be fully vaccinated against COVID-19 as of their start date. This requirement is a …

Linkedin.com

Coherus BioSciences (CHRS) Expected to Beat Earnings Estimates: …

2020-10-29  · Coherus BioSciences (CHRS) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended September 2020. This widely-known consensus outlook gives a good sense of the

Microsmallcap.com

Coherus BioSciences, Inc. : UBS is neutraal gestemd over het aandeel

2022-06-14  · Het onderzoek van UBS bevestigt het advies voor aandeel en blijft Neutraal. | 26 juni 2022

Nl.marketscreener.com

Coherus BioSciences (CHRS) May Report Negative Earnings: Know …

2022-04-28  · For the last reported quarter, it was expected that Coherus BioSciences would post a loss of $0.61 per share when it actually produced a loss of …

Zacks.com

Junshi Biosciences and Coherus Receive Complete Response Letter …

2022-05-02  · About Coherus BioSciences Coherus is a commercial stage biopharmaceutical company building a leading immuno-oncology franchise funded with cash generated by its commercial biosimilar business. In 2021, Coherus in-licensed toripalimab, an anti-PD-1 antibody, in the United States and Canada. Coherus plans to resubmit a BLA for toripalimab for the …

Financialpost.com

Coherus BioSciences Oncology Territory Manager Salaries in Sabhā

Average salary for Coherus BioSciences Oncology Territory Manager in Sabhā: $175,000. Based on 1 salaries posted anonymously by Coherus BioSciences Oncology Territory Manager employees in Sabhā.

Glassdoor.com


Domains Expiration Date Updated

Site Provider Expiration Date
dcm-inc.com namecheap.com -1 Years, -334 Days
g20ys.org nic.ru -1 Years, -203 Days
radeecal.in publicdomainregistry.com -1 Years, -251 Days
flagsapi.com porkbun.com -1 Years, -139 Days
freefollower.net namesilo.com -1 Years, -136 Days
rodnik-altaya.com nic.ru -1 Years, -310 Days
hindichristiansongs.in rediff.co.in -2 Years, -4 Days
socrata.com registrar.amazon.com -1 Years, -344 Days
igorvitale.org we.register.it -1 Years, -322 Days
gherf.org domain.com -1 Years, -288 Days

    Browser All

    .com4.3M domains   

    .org1M domains   

    .edu40.9K domains   

    .net607.2K domains   

    .gov15.9K domains   

    .us31.2K domains   

    .ca44.9K domains   

    .de556.6K domains   

    .uk465.9K domains   

    .it34.4K domains   

    .au46.4K domains   

    .co33.9K domains   

    .biz13.9K domains   

    .info36.7K domains   

    .fr37.2K domains   

    .eu24.6K domains   

    .ru193.6K domains   

    .ph5.6K domains   

    .in54.2K domains   

    .vn18.8K domains   

    .cn39.8K domains   

    .ro19.3K domains   

    .ch11.5K domains   

    .at10.2K domains   

    Browser All